Does lisinopril (angiotensin-converting enzyme inhibitor) lower heart rate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril Does Not Lower Heart Rate

Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, does not significantly affect heart rate in hypertensive patients. The clinical pharmacology data shows that lisinopril produces a smooth, gradual blood pressure reduction without affecting heart rate or cardiovascular reflexes 1.

Mechanism of Action and Hemodynamic Effects

  • Lisinopril works primarily by inhibiting ACE activity, which reduces plasma angiotensin II and aldosterone while increasing plasma renin activity 1.
  • In hemodynamic studies of lisinopril in patients with essential hypertension, blood pressure reduction was accompanied by a reduction in peripheral arterial resistance with little or no change in cardiac output and heart rate 2.
  • Unlike beta-blockers or certain calcium channel blockers (such as verapamil or diltiazem), ACE inhibitors like lisinopril do not directly affect the sinoatrial node or cardiac conduction system 3.

Clinical Evidence

  • In a study using ambulatory blood pressure monitoring in patients with moderate hypertension, lisinopril effectively reduced blood pressure but did not alter heart rate 4.
  • When compared with other antihypertensive medications in clinical trials, lisinopril demonstrated superior reductions of systolic and diastolic blood pressure compared to hydrochlorothiazide, and was approximately equivalent to atenolol and metoprolol in reducing diastolic blood pressure, but without the heart rate-lowering effects typically seen with beta-blockers 2, 5.
  • In patients with heart failure and atrial fibrillation, lisinopril improved peak oxygen consumption but did not significantly affect heart rate during exercise or ambulatory monitoring 6.

Contrast with Other Antihypertensive Medications

  • Unlike beta-blockers (such as atenolol or metoprolol) which directly reduce heart rate as part of their mechanism of action, ACE inhibitors like lisinopril lower blood pressure primarily through vasodilation 3.
  • Certain calcium channel blockers, particularly non-dihydropyridines like diltiazem and verapamil, can significantly reduce heart rate, unlike ACE inhibitors 3.
  • Ivabradine is specifically designed to lower heart rate by inhibiting the If current in the sinus node, a mechanism completely different from lisinopril's ACE inhibition 3.

Clinical Implications

  • When heart rate reduction is a therapeutic goal (such as in certain cases of angina or inappropriate tachycardia), medications like beta-blockers or ivabradine would be more appropriate choices than lisinopril 3.
  • The lack of heart rate reduction with lisinopril may be advantageous in patients where bradycardia would be problematic or where maintaining cardiac output is important 3.
  • In patients with heart failure, lisinopril increases cardiac output and decreases pulmonary capillary wedge pressure and mean arterial pressure without significant changes in heart rate 2.

Common Misconceptions

  • It's important to distinguish between the effects of different antihypertensive drug classes - while some (beta-blockers, non-dihydropyridine calcium channel blockers) directly reduce heart rate, ACE inhibitors like lisinopril do not 3.
  • The blood pressure lowering effect of lisinopril begins within 2 hours, peaks around 6 hours, and lasts for at least 24 hours, but throughout this cycle, there is no significant impact on heart rate 1.

References

Research

The clinical pharmacology of lisinopril.

Journal of cardiovascular pharmacology, 1987

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lisinopril in the treatment of hypertension.

Journal of human hypertension, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.